EP
Erik Pär Pelle Redare
Ceo - Chief Executive Officer at Icellate Medical
View Erik's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Ceo - Chief Executive Officer
Present
Company Details
11-50 Employees
iCellate develops and provides cancer profiling services for precision oncology. iCellate’s CellMate® is a next generation circulating tumor cell (CTC)-based platform for cancer cell detection and comprehensive biomarker analysis. GeneMate® is an analysis for hereditary cancer and gBRCA testing.
Website
Year Founded
2011
Social Media
LinkedinFacebookTwitter
Industry
Medical and Diagnostic Laboratories, Pathological and clinical laboratories, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Scientific Research and Development Services, Services
HQ Location
Industrivägen 1
Solna, Stockholm 171 48, SE
Keywords
Cancer DiagnosticsCirculating Tumor Cells (CTC)Liquid BiopsyNext Generation SequencingCDxHereditary CancerEarly DetectionCancerand Solid Tumorscancer cell detection
Contact Details
- Email AddressE**@icellate.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
Find verified contacts of Erik Pär Pelle Redare in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.